Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Autism
- Gastric Cancer
- Pathology
- Nuclear Medicine
- Cardiac Surgery
- Pneumonia
- Pharmacology and Therapeutics
- Breast Neoplasms
Abstract
Citation: Clin Case Rep Int. 2023;7(1):1535.DOI: 10.25107/2638-4558.1535
One-Year Assessment of Body Composition in Cystic Fibrosis Patients on Elexacaftor-Tezacaftor-Ivacaftor
Zamponi V, Cirilli N, Caporelli N, Fabrizzi B, Strappato M, Mignini EV, Nicolai G, Nicolai A and Taus M
University Hospital of the United Hospitals of Ancona, Italy
*Correspondance to: Taus Marina
PDF Full Text Short Communication | Open Access
Abstract:
#
Keywords:
#
Cite the Article:
Zamponi V, Cirilli N, Caporelli N, Fabrizzi B, Strappato M, Mignini EV, et al. One-Year Assessment of Body Composition in Cystic Fibrosis Patients on Elexacaftor-Tezacaftor-Ivacaftor. Clin Case Rep Int. 2023; 7: 1535.